Explore groundbreaking studies, experimental findings, and scientific advancements shaping the future of regenerative medicine
Breakthrough in GMP-compliant iPSC therapy for recessive dystrophic epidermolysis bullosa (RDEB) treatment using genetically reprogrammed skin cells.